UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

There have been great advances in the field of generalised myasthenia gravis (gMG ... or the movement of the eyes, causing diplopia or double vision. Weakness can also be located in the bulbar muscles ...

Medications for myasthenia gravis (MG) can include cholinesterase inhibitors, corticosteroids, immunosuppressants, monoclonal antibodies, and antibody fragment medications. While myasthenia gravis ...

Myasthenia gravis, a rare autoimmune condition affecting nerve conduction, is another common factor linked with ptosis.

Myasthenia gravis (MG) is an autoimmune disorder involving complex interactions between genetic and environmental factors. Genome-wide association studies (GWAS), transcriptome-wide association ...

Test Your Knowledge About the Surgical Management of Myasthenia Gravis Test Your Knowledge About the Histology of Myasthenia Gravis Test Your Knowledge About the Clinical Features of Myasthenia Gravis ...